At least vaxx makers detailed the ingredients and adverse events in their package inserts, as required:
" 1. Information Relating to the EUA Product
a. Information for Health Care Professionals or Authorized Dispensers
For an unapproved product (section 564(e)(1)(A)(i)) and for an unapproved use of an approved product (section 564(e)(2)(A)), FDA must (to the extent practicable given the circumstances of the emergency) establish conditions to ensure that health care professionals who administer the EUA product are informed:
- That FDA has authorized the emergency use of the product (including the product name and an explanation of its intended use);
- Of the significant known and potential benefits and risks of the emergency use of the product, and the extent to which such benefits and risks are unknown; and
- Of available alternatives and their benefits and risks.
Therefore, FDA recommends that a request for an EUA include a “Fact Sheet" for health care professionals or authorized dispensers that includes essential information about the product. In addition to the required information, Fact Sheets should include:
- A description of the disease/condition;
- Any contraindications or warnings;
- Dosing information (if applicable), including any specific instructions for special populations; and
- Contact information for reporting adverse events and additional information about the product.
Health care professionals or authorized dispensers will likely have very limited time to review Fact Sheets during an emergency and, therefore, FDA anticipates that Fact Sheets typically will be brief (i.e., a few pages). FDA makes available on its website Fact Sheets for products for which an EUA is issued.41"
https://www.fda.gov/regulatory-informat ... processing
https://www.youtube.com/watch?v=4v6DJIS0zd4